Who We Are

RIVVE Life Science is a specialized pharmaceutical commercialization platform focused on bringing innovative medicines to patients across the Gulf Cooperation Council (GCC) and the broader Middle East & North Africa (MENA) region.

Headquartered in Dubai, RIVVE partners with international pharmaceutical and biotechnology companies to accelerate market access, regulatory approvals, and successful product launches through a single integrated regional platform.

RIVVE acts as a strategic bridge between global pharmaceutical innovators and regional healthcare systems, providing expertise in regulatory strategy, market access, medical affairs, and commercial execution.

Our mission is simple: enable faster access to meaningful therapies for patients in the region while building sustainable value for our partners.

Who We Are

  • To become the leading commercialization partner for innovative medicines in GCC and MENA, recognized for delivering successful launches and compliant sustainable market growth.

  • To help global pharmaceutical companies successfully enter and expand in the GCC & Middle East through a flexible partnership model combining regulatory expertise, market access capabilities, and commercial execution.

  • RIVVE Life Science operates as a regional commercialization hub, coordinating all market activities through a master partnership model.

    Our structure allows international companies to work with one strategic partner while RIVVE manages:

    • Local distribution

    • Regulatory submissions

    • Market access strategy

    • Medical engagement

    • Commercial launch execution

    This model significantly reduces complexity & time to market for our partners.

  • Regulatory Strategy & Market Entry

    RIVVE supports partners in navigating the regulatory frameworks of GCC countries including:

    • United Arab Emirates

    • Saudi Arabia

    • Kuwait

    • Qatar

    • Bahrain

    • Oman

    Services include:

    • Regulatory strategy development

    • Dossier submission and lifecycle management

    • Pricing and reimbursement support

    Commercial Launch & Market Development

    RIVVE designs and executes tailored commercialization strategies to ensure successful product launches.

    Capabilities include:

    • Launch planning and execution

    • Field Force strategy and management

    • KOL engagement and scientific promotion

    • Commercial strategy and forecasting

    Medical Affairs & Scientific Engagement

    Our medical strategy ensures strong clinical credibility and physician engagement.

    Activities include:

    • Medical science liaison (MSL) engagement

    • Scientific education programs

    • Advisory boards and investigator relationships

    • Real-world evidence initiatives

    Market Access & Reimbursement

    Understanding the payer landscape is critical in GCC markets.

    Our expertise in :

    • Health authority engagement

    • Pharmacoeconomic value communication

    • Pricing strategy and reimbursement negotiation

    Distribution Network Management

    We manage local distribution through our trusted best-in-class licensed distributors in each country.

    This enables:

    • Full reach to private & Government market

    • Efficient product importation and supply

    • Compliance with local regulations

    • Scalable market expansion across the region

  • RIVVE Life Science operates through flexible partnership models designed around partner needs.

    Possible structures include:

    • Master distribution models

    • Commercialization partnerships

    • Launch support agreements

    • Product Inlicince

    Our objective is to create long-term partnerships focused on compliant sustainable growth and patient access.

  • Primary markets include:

    • Saudi Arabia

    • United Arab Emirates

    • Kuwait

    • Qatar

    • Bahrain

    • Oman

    RIVVE also supports expansion into the Middle East & North Africa (MENA) region.

  • RIVVE prioritizes innovative therapies in areas of high unmet medical need, including:

    • Pediatrics

    • Neurology

    • Psychiatry

    • Rare diseases

    • Dermatologist

    • Specialty Care

Core Capabilities

  • Regulatory Strategy

    RIVVE supports partners in navigating the regulatory frameworks of GCC countries :

    - Regulatory strategy development

    - Dossier submission and lifecycle management

    - Pricing and reimbursement support.

  • Commercial Launch

    RIVVE designs and executes tailored commercialization strategies to ensure successful product launches.

    - Launch planning and execution

    - Field Force strategy and management

    - KOL engagement and scientific promotion

    - Commercial strategy and forecasting

  • Medical Affairs

    Our medical strategy ensures strong clinical credibility and physician engagement.

    - Medical science liaison (MSL) engagement

    - Scientific education programs

    - Advisory boards and investigator relationships

    - Real-world evidence initiatives

  • Market Access

    Understanding the payer landscape is critical in GCC markets.

    - Health authority engagement

    - Pharmacoeconomic value communication

    - Pricing strategy and reimbursement negotiation

  • Distribution Network

    We manage local distribution through our trusted best-in-class licensed distributors in each country.

    - Full reach to private & Government market

    - Efficient product importation and supply

    - Compliance with local regulations

    - Scalable market expansion across the region

Key Therapeuitc Expertise

  • Neurology

  • Pediatrics

  • Psychiatry

  • Dermatologist

  • Specialty Care

  • Immunology

  • Oncology

Why Partner With RIVVE

  • 01

    One Regional Partner

  • 02

    Deep Understanding of GCC Regulatory and Market Access Pathways

  • 03

    Flexible Commercialization Models

  • 04

    Strong Relationships with Regional Distributors and Healthcare Stakeholders

  • 05

    Focus on Innovative and Specialty Medicines

Our Commitment

At RIVVE Life Science, we believe that every patient deserves access to the best available therapies.

By partnering with global pharmaceutical innovators, we work to ensure that life-changing medicines reach patients in the Middle East faster and more effectively.

Our Story

RIVVE represents the idea of flow, connection, and momentum in bringing innovative medicines to patients.

The name evokes the image of a river—a powerful channel that connects distant sources to the places where life depends on them. In the same way, RIVVE Life Science acts as the channel that connects global pharmaceutical innovation with patients and healthcare systems across the GCC and Middle East.

  • Many breakthrough therapies are developed globally, but reaching patients in emerging markets often requires navigating complex regulatory systems, fragmented distribution networks, and diverse healthcare environments. RIVVE was created to Simplify The Journey.

  • RIVVE Life Science was founded by industry experts with extensive experience in pharmaceutical commercialization, market access, and regional market development across the Middle East.

    Through years of working with international pharmaceutical companies, regional distributors, healthcare authorities, and key opinion leaders, the founders recognized a recurring challenge:

    Global companies needed a trusted regional partner capable of navigating the complexity of the Middle East while executing high-quality launches and compliant sustainable market growth.

  • By combining deep regional expertise, strong healthcare stakeholder relationships, and a flexible commercialization model, RIVVE provides international partners with a single regional platform to manage regulatory entry, medical engagement, market access strategy, and commercial execution allowing global pharmaceutical companies to enter the region efficiently while maintaining strategic oversight.

The Double “V” in RIVVE

  • Value for Partners

  • Voice for Patients

  • Velocity to Market

OUR FOUNDERS

Having witnessed firsthand the challenges global companies face when entering the region, the founders established RIVVE Life Science to provide a dedicated commercialization platform capable of bridging global innovation with regional execution.

Their vision was to build a company that combines deep regional expertise, global compliance standards, strong healthcare relationships, and flexible partnership models to help international pharmaceutical innovators expand to Middle East.

RIVVE Life Science was founded by pharmaceutical industry professionals with extensive experience in commercialization, market access, and regional market development across the GCC and Middle East.

Throughout their careers, the founders have worked closely with international pharmaceutical companies, regional distributors, healthcare authorities, and leading medical experts, successfully supporting the introduction and growth of innovative therapies in complex healthcare markets.

Let’s Work Together